블로그
- [에이프릴바이오] LB1228 EVO301: a potent, novel IL18 inhibiting biologic demonstrating robust preclinical data for the treatment of atopic dermatitis Translational Studies: Preclinical ePoster Talk Session 1: Late-Breaking Abstracts
- 유크리사(eucrisa)/크리사보롤(cribosarole)-무엇이 나의 아이를 아토피 피부염 환자로 만드는가 The use of topical antihistamines for the treatment of patients with atopic dermatitis is not recommended because of the risk of absorption and of contact dermatitis.
-
유크리사(eucrisa)/크리사보롤(cribosarole)-무엇이 나의 아이를 아토피 피부염 환자로 만드는가
The use of topical antihistamines for the treatment of patients with atopic dermatitis is not recommended because of the risk of absorption and of contact dermatitis.
